Jin Medical International Ltd.
ZJYL
$0.5852
$0.00581.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -6.40% | -6.40% | 35.29% | 35.29% | 2.96% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.40% | -6.40% | 35.29% | 35.29% | 2.96% |
| Cost of Revenue | 8.71% | 8.71% | 14.37% | 14.37% | 2.10% |
| Gross Profit | -33.30% | -33.30% | 74.44% | 74.44% | 4.53% |
| SG&A Expenses | 15.73% | 15.73% | 98.14% | 98.14% | 68.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 113.77% | 113.77% | -40.92% | -40.92% | -40.08% |
| Total Operating Expenses | 10.81% | 10.81% | 24.35% | 24.35% | 9.97% |
| Operating Income | -136.95% | -136.95% | 119.89% | 119.89% | -30.61% |
| Income Before Tax | -98.58% | -98.58% | 73.41% | 73.41% | 2.18% |
| Income Tax Expenses | -93.66% | -93.66% | 225.79% | 225.79% | 51.47% |
| Earnings from Continuing Operations | -99.47% | -99.47% | 54.29% | 54.29% | -3.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -209.13% | -209.13% | -- | -- | -- |
| Net Income | -104.96% | -104.96% | 69.26% | 69.26% | 1.56% |
| EBIT | -136.95% | -136.95% | 119.89% | 119.89% | -30.61% |
| EBITDA | -123.94% | -123.94% | 109.34% | 109.34% | -28.46% |
| EPS Basic | -105.26% | -105.26% | 66.67% | 66.67% | -12.31% |
| Normalized Basic EPS | -106.98% | -106.98% | 96.00% | 96.00% | -6.52% |
| EPS Diluted | -105.26% | -105.26% | 66.67% | 66.67% | -12.31% |
| Normalized Diluted EPS | -106.98% | -106.98% | 96.00% | 96.00% | -6.52% |
| Average Basic Shares Outstanding | 0.09% | 0.09% | 0.96% | 0.96% | 15.66% |
| Average Diluted Shares Outstanding | 0.09% | 0.09% | 0.96% | 0.96% | 15.66% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |